Drug Target Review

DECEMBER 11, 2024

Such an approach ensures reliable preclinical toxicology data and supports the transition of innovative therapies from the lab to clinical trials. For small- and medium-sized pharmaceutical companies, outsourcing represents a strategic leap forward, offering a gateway to unparalleled expertise and cutting-edge analytical technologies.

International

Drug Patent Watch

DECEMBER 9, 2024

This includes: Preclinical studies Clinical trials Regulatory approval Manufacturing and marketing Throughout this process, pharmaceutical companies seek to protect their investments through patents.

Drugs

The Pharma Data

JUNE 25, 2025

Novartis Finalizes Acquisition of Regulus Therapeutics, Strengthening Its Renal Disease Portfolio with Promising ADPKD Therapy Novartis AG, a leading global pharmaceutical company, has officially completed its acquisition of Regulus Therapeutics Inc. , a biotechnology firm known for its expertise in microRNA-targeting therapies.

RNA

Alta Sciences

JUNE 6, 2025

For biotechnology and pharmaceutical companies, automation can decrease their drug-to-market development time and remain financially competitive in an evolving market. My experience as an optimization scientist has shown how automation can be a valuable tool to support drug development for sponsors of all sizes.

Pharmacokinetics

SugarCone Biotech

JUNE 19, 2025

Finally, while there are clear front runners among the pharmaceutical companies developing targeted therapeutics for these antigens there are also emerging biotechs aggressively pursuing these targets. This Phase 3 trial compared tarlatamab with chemotherapy as second-line treatment. months (versus 20% ORR and 8.3

Therapies

SugarCone Biotech

JUNE 27, 2025

Finally, while there are clear front runners among the pharmaceutical companies developing targeted therapeutics for these antigens there are also emerging biotechs aggressively pursuing these targets. That trial is in second-line NSCLC. Importantly, effective combinatorial approaches that include these targets are emerging.

Therapies

Drug Patent Watch

AUGUST 11, 2025

"Revolutionizing the Way We Prescribe: How Data-Driven Insights Are Redefining Formulary Automation As healthcare costs continue to soar, pharmaceutical companies, payers, and providers are under increasing pressure to optimize formulary management.

Clinical Trials

Drug Target Review

MARCH 4, 2025

The MyPhenome test has already gained traction among obesity specialists, particularly in Chicago and Florida, and Phenomix has formed strategic partnerships with multiple pharmaceutical companies to support clinical trials and further analyse obesity-related data.

Therapies

The Pharma Data

JUNE 13, 2025

This includes assistance in intellectual property strategy, securing funding, developing business plans, and preparing for eventual collaboration with large pharmaceutical companies or investors. The main objective of MEDISO is to aid Japanese drug-discovery ventures in navigating the complex path toward commercial readiness.

Research

The Pharma Data

JUNE 24, 2025

We are proud that our partnership with Tsinghua University has set a benchmark for scientific research collaboration between multinational pharmaceutical companies and high-profile academic institutions in China. “This progress is driven by the dedicated efforts and strong collaborations among innovators of science and business.

Pharma R&D

Alta Sciences

JULY 3, 2025

Attendees were particularly drawn to our integrated solutions, which encompass everything from lead candidates advancing to IND-enabling programs to early-phase clinical trials to full-scale commercial manufacturing.

Small Molecule

DrugBank

JUNE 18, 2025

The failure rate in clinical trials exceeds 90%, often due to insufficient safety data, efficacy concerns, or regulatory non-compliance. Even drugs that complete clinical trials may face delays or rejections if submission documents are incomplete or do not align with regulatory expectations.

Drug Development

Drug Target Review

MARCH 3, 2025

However, promising pilot data from ongoing collaborations with pharmaceutical companies suggest that brain organoids are set to become a valuable tool in preclinical research. This approach has the potential to revolutionise clinical trial design and lead to more effective, personalised treatments.

Disease

Drug Target Review

JULY 14, 2025

Ignota Labs specialises in identifying failed drug candidates, resolving their issues and turning them around before selling them back to pharmaceutical companies. By this point, companies have invested heavily in their assets but have not yet reached human trials.

Drugs

Advarra

DECEMBER 17, 2024

For example, AI tools can pull data from protocols and automatically update clinical trial management systems (CTMS), reducing manual entry errors and increasing workflow speed. This same data could be used to auto-generate study calendars based on the schedule of assessments, streamlining trial planning.

Clinical Research

Codon

NOVEMBER 3, 2024

Still, while these developments provide cause for hope, each drug or vaccine faces a variety of challenges, ranging from financial incentives for clinical trials to the difficulty of discovering new antimicrobials that pass safety and efficacy tests. A phase 3 clinical trial for M72/AS01E, funded by the Gates Foundation, began this year.

Vaccine

ACTO

AUGUST 11, 2025

About Global Data Support (GDS) Global Data Support (GDS) helps biopharma and pharmaceutical companies find patients, profile experts, and map treatment landscapes—especially in rare diseases and oncology.

Disease

BioPharma Drive: Drug Pricing

JUNE 11, 2025

Ibtrozi was approved based on a pair of trials showing response rates of 90% and 85%, respectively, in patients who hadn’t previously received another tyrosine kinase inhibitor. Among those who had gotten another such therapy, the rates were 52% and 62% in those trials. Informa PLCs registered office is 5 Howick Place, London SW1P 1WG.

FDA

SugarCone Biotech

JULY 6, 2025

Finally, while there are clear front runners among the pharmaceutical companies developing targeted therapeutics for these antigens there are also emerging biotechs aggressively pursuing these targets. Each target and each therapeutic modality induces varying degrees of clinical efficacy, as well as causing toxicities.

Drug Development

The Pharma Data

JUNE 20, 2025

Groundbreaking Data from the Phase III ARANOTE Trial The CHMP’s recommendation is founded on data from the pivotal Phase III ARANOTE clinical trial, which demonstrated that darolutamide, when used in combination with ADT, significantly reduced the risk of radiological progression or death in patients with mHSPC. 0.71; P<0.0001).

Trials

The Premier Consulting Blog

DECEMBER 16, 2024

Pharmaceutical companies may, at times, find themselves at an impasse during development, facing weighty decisions about whether to slow down or hit the brakes on a development program. These decisions are complex, multi-dimensional, and can have significant impact on the future of the company.

Pharmacokinetics

Drug Target Review

MAY 26, 2025

“A big part of my role involves interacting with customers, learning from them on their challenges and providing solutions to expedite their path to clinical trials or commercialisation of their drug,” Galbraith explains. Even large pharmaceutical companies often rely on CROs for their expertise and resources.

Drug Development

BioPharma Drive: Drug Pricing

JULY 16, 2025

But the steady expansion of their use has slowed and, despite much trying, pharmaceutical companies have largely failed to top the drugs’ successes. But the steady expansion of their use has slowed and, despite much trying, pharmaceutical companies have largely failed to top the drugs’ successes.

Therapies

BioPharma Drive: Drug Pricing

JULY 10, 2025

But the steady expansion of their use has slowed and, despite much trying, pharmaceutical companies have largely failed to top the drugs’ successes. But the steady expansion of their use has slowed and, despite much trying, pharmaceutical companies have largely failed to top the drugs’ successes.

Drugs

Reprocell

NOVEMBER 14, 2024

To address the issues of time and cost, pharmaceutical companies rely on central laboratories (CLs) for consistency, organization, and efficiency during the clinical trial phase, which is essential for drug approval.

Marketing

BioPharma Drive: Drug Pricing

JUNE 24, 2025

Interim results from an early-stage trial last year showed Lexeo’s Friedreich’s ataxia drug, LX2006, reduced signs associated with heart complications among a small group of study participants. You can unsubscribe at anytime. Both programs are in early human studies. By Jonathan Gardner • Sept. By Jonathan Gardner • Sept. TechTarget, Inc.s

RNA

BioPharma Drive: Drug Pricing

JULY 9, 2025

Deep Dive Library Events Press Releases Topics Sign up Search Sign up Search Pharma Biotech FDA Clinical Trials Deals Drug Pricing Gene Therapy An article from Merck to buy Verona and its lung drug in $10B deal The New Jersey-based pharma has inked one of the biggest deals of the year in pursuit of a promising new way to treat COPD.

Clinical Trials

BioPharma Drive: Drug Pricing

JULY 14, 2025

Partners Group, another existing equity holder, is making a minority investment, the company said. PCI helps biopharmaceutical companies manufacture and package drug products used in clinical trials as well as commercially. You can unsubscribe at anytime. By Jonathan Gardner • Sept. 4, 2024 Keep up with the story.

Production

Drug Patent Watch

JANUARY 8, 2025

Drug patents are a form of intellectual property protection that grants pharmaceutical companies exclusive rights to manufacture, sell, and profit from their innovations for a set period. This exclusivity is the lifeblood of the industry, allowing companies to recoup their substantial R&D investments and fund future discoveries.

Pharmaceutical Companies

Codon

JULY 14, 2025

However, in a Bayer management meeting to discuss whether acetylsalicylic acid should go forward to clinical trials, Dreser asserted that it was a direct cardiac poison and opposed it progressing to trials. Dreser had the right to veto any drug going to clinical trials, so this is where the story of aspirin could have ended.

Treatment

BioPharma Drive: Drug Pricing

OCTOBER 16, 2024

The results provide the first clinical evidence of RNA editing, a burgeoning field that's drawn interest from biotechs and pharmaceutical companies alike.

RNA

PPD

AUGUST 16, 2023

The COVID-19 pandemic rapidly accelerated the adoption of hybrid and decentralized clinical trial (DCT) models. However, as the world settles into its post-pandemic state and returns to pre-pandemic paradigms in many areas, the pharmaceutical industry remains dedicated to moving beyond traditional, centralized clinical trial constructs.

Clinical Trials

BioPharma Drive: Drug Pricing

AUGUST 17, 2023

The German pharmaceutical company is launching three Phase 3 trials of an obesity drug called survodutide, which like Wegovy targets the GLP-1 receptor

Pharmaceutical Companies

H1 Blog

DECEMBER 4, 2023

As the pharmaceutical and biotech industries continue to push for faster drug development, the importance of equity and diversity in clinical trial recruitment cannot be overlooked. Data is a powerful tool in identifying and reaching vulnerable populations for clinical trials.

Clinical Trials

Conversations in Drug Development Trends

DECEMBER 7, 2023

Amidst a shifting clinical landscape characterized by increasingly complex trial designs and growing patient subpopulations, many contract research organizations (CROs) have adopted a “one-stop-shop” strategic approach. Moreover, these delays impact getting potentially lifesaving therapies to patients in need.

Clinical Trials

DrugBank

MARCH 7, 2024

Inspired by its success, pharmaceutical companies are pursuing the development of drugs with similar therapeutic profiles, aiming to expand treatment options. Key Players and Challenges For pharmaceutical giants like Novo Nordisk and Eli Lilly, 2024 presents both opportunities and challenges.

Pharmaceutical Companies

Drug Channels

FEBRUARY 7, 2024

Tomorrow, we’ll be treated to a Senate show trial featuring pharmaceutical company executives. In reality, nearly all drug spending growth occurred due to growth in the number of people treated, prescriptions dispensed, and other nonprice factors. healthcare expenditures.

Drugs